Category: Clinical Trial Update Region: Asia · China Company: Jiangsu Ascentage Pharma Inc

The Key Registration Phase Iii Study Of Neriq

The Key Registration Phase Iii Study Of Neriq
Ascentage Pharma (6855.Hk) Announced Today That The Company'S Core Product Orebatinib (Trade Name: Neriq

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!